Purpose: Cone beam CT is increasingly being used for daily patient positioning verification during radiation therapy treatments. The daily use of CBCT could lead to accumulated patient doses higher than the older technique of weekly portal imaging. There have been several studies focusing on measurement or calculation of the patient dose from CBCT recently. Methods: This study investigates the feasibility of configuring a kV x-ray source in a commercial treatment planning system to calculate the dose to patient resulting from an IGRT procedure. The method proposed in this article can be used to calculate dose from CBCT imaging procedure and include that in the patient treatment plans. Results: The kilovoltage beam generated by the CBCT imager has been modeled using the planning system. The modeled profiles agree with the measured ones to within 5%. The modeled beam was used to calculate dose to phantom in the pelvic region and the calculations were compared to TLD measurements. The agreement between calculated and measured doses ranges from 0% to 19% in soft tissue with larger variations observed near and within the bone.
I. INTRODUCTION
Cone beam CT ͑CBCT͒, is a relatively new imaging modality commonly installed on linear accelerators ͑LINACs͒ and used for image guided radiation therapy ͑IGRT͒. The radiation source used to obtain CT images is either the megavoltage beam produced by the LINAC itself or an additional kilovoltage ͑kV͒ x-ray tube/image receptor installed perpendicularly to the megavoltage beam axis.
In general, daily use of CBCT adds to the radiation dose given to patients to a greater amount than that given by the traditional weekly portal imaging. For example, Wen et al. 1 measured the cumulative kV CBCT dose in pelvic bones to be ϳ400 cGy during the treatment of prostate in a total of 42 fractions. Ding et al. 2 reported the dose resulting from a single fraction kV CBCT acquisition being as high as 25 cGy in cranial bones. The AAPM Task Group 75 report 3 addresses the issue of imaging dose from CBCT and makes recommendations on reducing, as well as estimating, the dose to patient.
There have been several papers on measuring the dose from CT in phantom and on patient using various dosimeters or by Monte Carlo methods.
1,2,4-8 Inclusion of this dose in the treatment planning process is the subject of additional investigations. In the case of megavoltage CBCT imaging, since the radiation beam used for imaging is the same as the one used for treatment planning, the addition of the imaging dose to the treatment plan is a relatively straightforward process. For example, Miften et al. 9 incorporated the daily dose from megavoltage CT in the IMRT treatment planning optimization.
In the case of kilovoltage CT imaging, however, the inclusion of the imaging dose requires defining the kilovoltage beam characteristics, adding the beam data, and commissioning the planning system for this purpose. This work is the first attempt in modeling a kilovoltage CBCT beam in a commercial treatment planning system.
Including the imaging dose at the time of planning would allow for a better prediction of the total dose to tumor and critical organs since this dose can be accounted for at the time of optimization for IMRT planning, or can simply be added to the treatment plan in the case of conventional planning. For kilovoltage beams, there is also the consideration of additional dose to bone, which may affect the dose distribution within the patient to a greater degree. Accounting for the dose to patient resulting from image guidance procedures in the stage of treatment planning can also provide choices for clinicians to make an informed decision regarding the risk and benefits of additional radiation exposure.
This investigation focuses on modeling the kilovoltage beam from Varian's on-board imager ͑OBI͒ system installed on the Varian linear accelerators in a commercial treatment planning system.
II. MATERIALS AND METHODS

II.A. Beam modeling
We have modeled the kV CBCT beam from a Varian OBI system on a Trilogy linear accelerator ͑Varian Medical Systems, Palo Alto, CA͒ in the Philips PINNACLE treatment planning system v8.0 ͑Philips Medical Systems, Milpitas, CA͒. The OBI system has been extensively described elsewhere. 1, 10 In brief, the system consists of an x-ray tube capable of producing x-ray beams with the peak energy range of 40-125 kV and an image receptor at 140-170 cm from the source with a 100 cm isocenter. The CBCT images can be acquired in full-fan or half-fan modes. Additional aluminum filters called the bowtie are used during acquisition to improve image quality. In the full-fan mode, the full bowtie filter is usually used while in the half-fan mode the half-bowtie filter is used. This study concentrates on using the 125 kVp beam and a half-fan beam acquisition with a half-bowtie, but it can be extended to include other beam qualities and acquisition modes.
In order to model a beam in the kilovoltage energy range, the PINNACLE system's capabilities have been extended with the addition of monoenergetic energy deposition kernels in the range of 20-110 keV, details of which have been explained previously. 11, 12 The x-ray beam modeled here has technical settings of 125 kVp and 80 mA, and acquired at half-fan mode with a half-bowtie filter. The blade settings are at X1 = 8.3 cm, X2 = 24.9 cm, Y1=Y2 = 11.8 cm. In order to model the halfbowtie filter, a wedge mimicking the filter has been added to the beam ͑Fig. 1͒. The beam spectrum was generated by Monte Carlo 2,10 and used as the baseline spectrum for modeling.
The beam data used for modeling consist of the depth dose curve, three profiles parallel to the bowtie ͑wedge͒ direction at depths of 1, 5, and 10 cm, and one profile in the perpendicular direction at a depth of 5 cm. The data were generated using Monte Carlo and verified by measurement.
2, 10 The beam outputs for a specific CBCT scan determined by measured values in phantom were entered in the system as cGy/MU, with 1 MU being equivalent to 1 min. The choice of time would make it possible to enter acquisition times for a particular imaging study in lieu of monitor units which are meaningless in CBCT imaging.
Due to the shape of the cross profiles and the bowtie ͑wedge͒ filter, automodeling routines of the planning system were not usable, thus the beam modeling was performed manually and through an iterative process. Various factors, including the beam spectrum, electron contamination parameters, effective source size, and the shape of the filter were modified in order to obtain an acceptable model, i.e., obtaining the best fit for all profiles with the minimum difference between measured and modeled values. For example, the filter shape and density was changed several times and the one depicted in Fig. 1 is the finally accepted, and not the initially designed, one.
II.B. Dose calculations
The modeled kV CBCT beam was used to compute the dose from the CBCT procedure on a Rando body phantom ͑The Phantom Laboratory, Salem, NY͒. The goal here was to calculate the dose in the phantom measured by Wen et al.
1 in which they utilized thermoluminescent dosimeters ͑TLDs͒ for dose measurements. So, the image data set acquired in that study was used to compute the doses and the same blade settings and acquisition mode was reproduced in the planning system. Depending on treatment planning ͑based on CT͒ or adaptive radiotherapy planning ͑ART planning, based on CBCT͒, either a conventional CT-to-density curve or a CBCT-to-density curve could be used to correct for inhomogeneities. It is also possible to calibrate kV CBCT so that a single curve can be used for both. In this study, we calculated the KV dose based on planning CT and therefore a conventional CT-to-density curve was used.
A typical CBCT image acquisition on OBI system consists of hundreds of projections over an arc of 200°or more. This particular acquisition consists of 660 projections over a 370°arc. Reproducing this number of beams in a treatment planning system is time consuming and prohibitive in terms of system usage. However, these discrete projections can be estimated in the planning system as arcs. PINNACLE system computes arcs as a multitude of stationary beams, one every 5°by default. The 5°increment, however, can be changed. So, comparison was made between using 5°and 1°incre-ments and the resultant dose distributions were virtually identical, so the 5°increment was used to speed up calculations. In order to reproduce a 370°rotation for the current study, three arcs were created in PINNACLE. The choice of the arcs was to reproduce the measurements done by Wen, 1 including the overlap on the left side of the phantom and accounting for variable gantry speeds at the start and end positions. The beam arrangements and weightings used are shown in Table I . This beam arrangement constitutes calcu-FIG. 1. The image of half-bowtie filter ͑left͒ and the profile of the wedge mimicking it in Pinnacle ͑right͒. Note that the wedge profile orientation is reverse of the bowtie filter. The profile was entered in this orientation due to the planning system limitation and all the fields were given an 180°colli-mator rotation to match the filter orientation. The wedge is assigned a density of 7.8 g/cc.
lation of 75 stationary beams to mimic the 370°arc rotation. The calculated doses were then compared to measured values by examining the point doses at the locations of TLD measurements.
III. RESULTS AND DISCUSSION
III.A. Beam modeling
The resultant modeled depth dose and cross profiles are shown in Figs. 2͑a͒-2͑e͒. In these figures, solid lines represent measured profiles as reported by Ding 10 and dashed lines represent computed ones. The half-bowtie filter wedge is always present in the beam for both modeling and calculations. As seen in the figure, there are reasonable agreements between the modeled and measured profiles. The percent error for depth dose curves as reported by the planning system for all points except surface is 4% with the surface point being 5%. The percent error is calculated as ͑computed-measured͒/max depth dose. The same quantity for all cross profiles is better than 3% except for regions of steep dose drop-off and out-of-the-field areas. This value is defined as ͑computed-measured͒/central axis dose.
III.B. Dose calculations
Dose calculations using the three-arc beam arrangement ͑Table I͒ indicate a difference in the range of 0% to 19% between planned and measured doses for points within the soft tissue portion of phantom. These results are tabulated in Table II . Point index numbers correspond to TLD locations indicated on Fig. 3 . The calculated dose around each point was investigated and there is essentially no dose gradient within the approximate area occupied by each TLD chip. One should note that although percentage differences of up to 19% are observed, the absolute dose differences are in the order of 0.8 cGy or less. Since the range of doses measured/ calculated is between 2 and 5 cGy, small absolute dose differences translate to large percentage differences.
In the areas near and inside the bone, larger differences, up to 70%, are observed ͑Table III͒. The convolution/ superposition algorithm employed in PINNACLE is based on the energy deposition kernels generated in water 13 and relies on density scaling theorem 14 to scale the dose in materials of varying densities but the same atomic number. This approach works well in the megavoltage energy range but does not in the kilovoltage energies. To examine this further, the plan was recomputed ignoring inhomogeneity corrections. The resultant uncorrected bone doses were virtually identical ͑ei-ther the same value or within 0.1 cGy͒.
Assuming the average energy of the 125 kVp beam to be 45 keV, the mass energy absorption coefficient for bone is about five times that of soft tissue. 15 Therefore, it is not possible to obtain accurate doses near and inside the bone using this algorithm. In previous work, 12, 16 the accuracy of dose calculations in this energy range was evaluated and it was shown that calculations in high atomic number materials such as bone suffer from major inaccuracies. A proposed work-around to account for increased bone absorption using modified CT-to-density table 12 would work for simple geometry but proved inadequate in this study for points near and inside the bone using humanoid CT data.
III.C. Correction of bone dose
In the absence of more accurate dose calculation algorithms for kilovoltage beams, a manual postprocessing method could be employed to correct for the dose. Table IV is the result of such postprocessing. The "corrected dose" values in the table are obtained by multiplying the PINNACLE "computed dose" values by the ratio of bone/water mass energy absorption coefficients obtained from Table X of AAPM  Task Group 61 report, 17 assuming a 5.4 mm HVL for the 125 kVp beam measured before. 10 As seen in the table, this results in improved agreement between measured and calculated values, although there is still a difference of up to 30%. It should be noted that the "measured" bone dose values were not in fact measured but rather calculated, 1 hence there are large uncertainties ͑up to 15%͒ associated with them.
It should also be noted that this postprocessing method assumes a constant energy for the beam even though the energy of the kilovoltage beam changes with depth. In addition the phantom thickness varies as the beam rotates around it so the beam energy at any one point depends on the thickness it traverses the medium from all directions and is not a constant value. Further improvement in bone dose calculations requires a new algorithm such as the one proposed by Ding.
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IV. CONCLUSIONS AND DISCUSSIONS
This study demonstrates the feasibility of modeling a kV x-ray beam used for IGRT in a commercial treatment planning system. The kV beam was successfully modeled and its accuracy was evaluated. The results obtained from modeling the kV CBCT beam and calculating dose from this imaging modality in the treatment planning can provide for an easy estimation of imaging dose for all patients as part of their treatment plans. This will lead to better accounting of imaging dose prior to the commencement of treatment which will prevent potential overdosing of sensitive organs.
More work is needed to improve the accuracy of dose calculation by better accounting for variable gantry speeds and different filters used. Potential improvements in the modeling could reduce the uncertainties in dose calculation in soft tissue. The planning system's ability to predict dose to lung will also need to be evaluated further. But the major limitation of the system remains in its inability of predicting the dose in and near bony structures. This limitation can only be overcome by introducing newer algorithms capable of accounting for atomic number changes.
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